Backed by Amgen Ventures, Fortuna Fix secured $25M in funding to push its autologous stem cell treatments for Parkinson's disease and spinal cord injuries into the clinic. Source: BioSpace
The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace
Nearly four months after issuing a voluntary recall of all lots of unexpired sterile drug products, Cantrell Drug Company has filed for bankruptcy. Source: BioSpace
Five Prime stock took a beating after it unintentionally released Phase Ia/Ib clinical trial of its CSF-1R antibody cabiralizumab with BMS' Opdivo (nivolumab). Source: BioSpace
Proceeds will be used to complete the ongoing pivotal TRCA-301 Phase 3 clinical trial of TRC101. Source: BioSpace
Kerrisdale believes that Prothena's lead drug NEOD001 will fail in its current Phase 2b and Phase 3 trials. Source: BioSpace
Exonics Therapeutics closed on a $40M Series A financing which was led by The Column Group. Source: BioSpace
The hearing will focus on the therapeutic potential and ethical issues of using CRISPR technology to alter human DNA. Source: BioSpace
The FDA is seeking public comment on a proposed template for the submission of electronic data to the agency from clinical trials. Source: Drug Industry Daily
A group of investment funds sued Allergan, accusing the company of artificially inflating its stock by conspiring with other manufacturers of generic drugs. Source: Drug Industry Daily